September 2026 - BillionDollarClub

MondaySep 21, 2026 9:45 am

VERAXA Biotech AG (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase

VERAXA is advancing an oncology pipeline centered on its proprietary BiTAC(R) platform, alongside additional antibody-drug conjugate and engineered-antibody technologies. The company entered the NASDAQ market in June 2026 following its completed business combination with Voyager Acquisition Corp., giving VERAXA access to the U.S. public markets as it advances its development programs. BiTAC is designed as an “AND-gated” therapeutic approach in which two complementary components must engage the same cancer cell before the intended cytotoxic mechanism is activated. VERAXA has reported early preclinical evidence for both its BiTAC-TCE and BiTAC-ADC approaches, including an in-vitro proof of concept for BiTAC-ADC announced in…

MondaySep 21, 2026 9:00 am

BOXABL Inc. (NASDAQ: BXBL) Opens M&A and Partnership Strategy Across Housing Supply Chain

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL, transforming the housing market, has launched a new initiative that calls for companies across the housing supply chain, including landholders, operators, and technology owners, to explore partnerships, mergers, acquisitions, and other combinations. The company is considering flexible transaction structures, including cash, stock, or combinations of the…

FridaySep 18, 2026 10:00 am

Extensive EV Battery Tests Uncover Vital Insights

Electric vehicle batteries may be lasting better than many people think, but new testing shows that there is a major difference between individual cars. A large study of at least 500,000 EV battery tests has found that vehicles of the same model can have very different levels of battery health. The study was carried out by Austrian battery diagnostics company AVILOO using tests conducted from 2022 to 2026. It covered 20 well-known electric vehicle models and used physical measurements of the batteries instead of relying only on information shown on the vehicle dashboard. The research measured battery State of Health,…

ThursdaySep 17, 2026 10:00 am

European EV Users See 33% Drop in Running Costs vs. Gas Cars

European EV drivers are seeing a growing financial advantage over people who use gasoline-powered cars, as the cost of running battery electric vehicles continues to fall. International Council on Clean Transportation (ICCT) data shows battery electric vehicles (BEVs) were about 33% more affordable to drive compared to gasoline cars across the EU in 2025. This gap has become even more important in 2026. Rising oil and fuel costs have increased the energy expenses of traditional cars, while the cost of powering electric vehicles has remained more stable. This is giving vehicle owners a stronger reason to consider electric cars beyond…

WednesdaySep 16, 2026 10:30 am

BOXABL Inc.’s (NASDAQ: BXBL) Factory-Built Housing Strategy Targets Large US Supply Gap

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL recently began trading on the Nasdaq, marking the latest stage in the company's ongoing expansion of its factory-built housing platform. The company is applying advanced manufacturing, automation and AI to standardize home production and improve construction efficiency. BOXABL is directly addressing major issues of the large…

TuesdaySep 15, 2026 10:00 am

BTC Fails to Break Above $81,000 as Investors Await Fed’s September Meeting

Bitcoin has struggled to break above $81,000 as investors turn their attention to the Federal Reserve’s September meeting. A stronger-than-expected U.S. jobs report has changed expectations about interest rates and added fresh uncertainty to the cryptocurrency market. U.S. employers added 162,000 jobs in August, well above the roughly 65,000 new jobs economists had expected. The unemployment rate remained at 4.1%. The figures showed that the labor market was stronger than many had anticipated, raising questions about whether the Federal Reserve still has enough reason to cut interest rates soon. Bitcoin reacted quickly to the news. The cryptocurrency fell from above…

TuesdaySep 15, 2026 9:45 am

BOXABL Inc. (NASDAQ: BXBL) Joins Nasdaq Following SPAC Merger Approval, Bringing Factory-Built Housing Model to Public Markets

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL has begun trading on Nasdaq under the ticker symbol BXBL. The move values BOXABL at approximately $3.5 billion, with approximately 350 million shares issued at $10 per share. The company has so far raised over $230 million from 50,000+ investors. BOXABL is pursuing a technology-driven approach…

TuesdaySep 15, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment modalities. Its proprietary BiTAC platform uses two complementary molecules that are designed to activate cytotoxic activity only when both recognize targets on the same tumor cell. The company is applying the BiTAC concept to both antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), with an emphasis on solid tumors. With ADCs and bispecific antibodies attracting substantial investment, VERAXA is operating in oncology markets where technological differentiation can have significant strategic value. VERAXA Biotech (NASDAQ: VRXA) is developing a new generation of antibody-based cancer therapies at a…

FridaySep 11, 2026 10:00 am

Trump on Collision Course with Voters as Most Americans Oppose Data Centers

President Donald Trump is facing growing opposition from American voters over the rapid spread of artificial intelligence data centers. A recent NBC News Decision Desk Poll established that 69 percent of survey participants oppose building AI data centers within their local areas, including 45% who strongly oppose the idea. The findings reveal a growing divide between the Trump administration’s support for AI development and the concerns of communities expected to host the facilities. Trump has argued that data centers bring jobs, investment, and lower taxes. In a post on Truth Social, he said communities that reject them risk becoming “backwards…

WednesdaySep 09, 2026 10:00 am

Australia Considers Requiring Social Media to Have Algorithm Opt-In Feature for Users

Australia is considering a major change to the way social media platforms use recommendation algorithms. The government is weighing whether users should have to actively choose to use these systems instead of having them switched on automatically when they create an account. The proposal is part of a wider government effort to reduce family as well as domestic violence and protect young people from harmful online content. Officials are increasingly concerned that social media platforms can quickly direct users toward violent, misogynistic and sexually harmful material. Tanya Plibersek, the minister for social services, has raised strong concerns about the role…

The exclusive home of the biggest and brightest companies covered by IBN.

Contact us: (512) 354-7000

Month: September 2026